>300-fold family-selective PARP14 inh. tool

90x IC50 coverage at 500 mpk BID PO in vivo

from PARP-preferring directed library + SBDD

Cell Chem. Bio., Mar. 10, 2021

Ribon Therapeutics, Cambridge, MA


The Ribon Therapeutics PARP14 inhibitor (RBN-012759) is a tool compound with >300x selectivity over all PARP family members. While PARP1/2 are well-known to drug hunters as synthetic lethal targets…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: